Literature DB >> 6890153

The current neurologic burden of illness and injury in the United States.

J F Kurtzke.   

Abstract

Estimates of the need for neurologists must be based ultimately on the frequency of neurologic disease. Community-based population surveys for diseases or injuries that have come to medical attention provide annual incidence rates per 100,000 population, point prevalence rates per 100,000, and average duration in years. For 61 disorders, including for 8 only those fractions that were thought to require neurologic attention, the annual incidence rates summed to 2500 per 100,000 or 2.5% of the population. For 55 of these conditions, including for 6 only the neurologic fraction and excluding all mental retardation, blindness, deafness, or psychosis, the point prevalence rates summed to 9500 per 100,000 population. Even if we also excluded all headache, all trauma, all alcoholism, and all vertebrogenic pain states, 3.6% of the general population at any one time should be under neurologic care. Substracting all these exclusions from the incidence rates similarly leaves more than 1 person in every 100 who each year will have a new neurologic disorder that requires the attention of a physician competent in clinical neurology.

Entities:  

Mesh:

Year:  1982        PMID: 6890153     DOI: 10.1212/wnl.32.11.1207

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Neurology in the United Kingdom. II: A study of current neurological services for adults.

Authors:  R Langton Hewer; V A Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

2.  The meaning of distal sensory loss and absent ankle reflexes in relation to age: a meta-analysis.

Authors:  Alexander F J E Vrancken; Sandra Kalmijn; Frans Brugman; Gabriël J E Rinkel; Nicolette C Notermans
Journal:  J Neurol       Date:  2005-11-23       Impact factor: 4.849

3.  Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease.

Authors:  V Fraix; J-L Houeto; C Lagrange; C Le Pen; P Krystkowiak; D Guehl; C Ardouin; M-L Welter; F Maurel; L Defebvre; A Rougier; A-L Benabid; V Mesnage; M Ligier; S Blond; P Burbaud; B Bioulac; A Destée; P Cornu; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 4.  Behavioral neuropsychology: past, present, and future direction with organically based affect/mood disorders.

Authors:  K Lawson-Kerr; P Smith; D Beck
Journal:  Neuropsychol Rev       Date:  1991-03       Impact factor: 7.444

Review 5.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

6.  Neurology and the new health care policies.

Authors:  G Rosati
Journal:  Ital J Neurol Sci       Date:  1996-04

Review 7.  A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.

Authors:  P L Wood; T S Rao; S Iyengar; T Lanthorn; J Monahan; A Cordi; E Sun; M Vazquez; N Gray; P Contreras
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

Review 8.  Spasticity after stroke. Epidemiology and optimal treatment.

Authors:  C F O'Brien; L C Seeberger; D B Smith
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

9.  Functional reorganisation of memory after traumatic brain injury: a study with H(2)(15)0 positron emission tomography.

Authors:  B Levine; R Cabeza; A R McIntosh; S E Black; C L Grady; D T Stuss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

10.  Patterns of acute stroke care in three districts of southern England.

Authors:  C D Wolfe; N A Taub; J Woodrow; E Richardson; F G Warburton; P G Burney
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.